Company intelligence / Profile preview

Optrel

Wattwil, St. Gallen, Switzerland

Ownership: Private
Development stage: Other

Overview

Optrel is a leading global supplier of high-quality face, eye, and respiratory protective devices used by industrial and healthcare workers. Their TH3-class respiratory systems filter 99.8% of harmful particles, with special focus on frontline and healthcare workers during infectious outbreaks.

Therapeutic areas: OtherInfectious DiseasesPulmonology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Optrel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Optrel.

Explore the full profile